AMICUS THERAPEUTICS INC's ticker is FOLD and the CUSIP is 03152W109. A total of 226 filers reported holding AMICUS THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 0.62 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $206,720 | -3.2% | 17,000 | 0.0% | 0.03% | 0.0% |
| Q2 2023 | $213,520 | +13.3% | 17,000 | 0.0% | 0.03% | +6.9% |
| Q1 2023 | $188,530 | -9.2% | 17,000 | 0.0% | 0.03% | -14.7% |
| Q4 2022 | $207,570 | +17.3% | 17,000 | 0.0% | 0.03% | +13.3% |
| Q3 2022 | $177,000 | -3.3% | 17,000 | 0.0% | 0.03% | 0.0% |
| Q2 2022 | $183,000 | +13.7% | 17,000 | 0.0% | 0.03% | +36.4% |
| Q1 2022 | $161,000 | -17.9% | 17,000 | 0.0% | 0.02% | -12.0% |
| Q4 2021 | $196,000 | +21.0% | 17,000 | 0.0% | 0.02% | +13.6% |
| Q3 2021 | $162,000 | -1.2% | 17,000 | 0.0% | 0.02% | 0.0% |
| Q2 2021 | $164,000 | -2.4% | 17,000 | 0.0% | 0.02% | -8.3% |
| Q1 2021 | $168,000 | +124.0% | 17,000 | +13.3% | 0.02% | +60.0% |
| Q4 2016 | $75,000 | -32.4% | 15,000 | 0.0% | 0.02% | -34.8% |
| Q3 2016 | $111,000 | +35.4% | 15,000 | 0.0% | 0.02% | +35.3% |
| Q2 2016 | $82,000 | -36.4% | 15,000 | 0.0% | 0.02% | -37.0% |
| Q1 2016 | $129,000 | -11.6% | 15,000 | 0.0% | 0.03% | -10.0% |
| Q4 2015 | $146,000 | -30.5% | 15,000 | 0.0% | 0.03% | -33.3% |
| Q3 2015 | $210,000 | -0.9% | 15,000 | 0.0% | 0.04% | +9.8% |
| Q2 2015 | $212,000 | +30.1% | 15,000 | 0.0% | 0.04% | +32.3% |
| Q1 2015 | $163,000 | +30.4% | 15,000 | 0.0% | 0.03% | +29.2% |
| Q4 2014 | $125,000 | +40.4% | 15,000 | 0.0% | 0.02% | +33.3% |
| Q3 2014 | $89,000 | +78.0% | 15,000 | 0.0% | 0.02% | +80.0% |
| Q2 2014 | $50,000 | +61.3% | 15,000 | 0.0% | 0.01% | +66.7% |
| Q1 2014 | $31,000 | – | 15,000 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Palo Alto Investors LP | 10,524,022 | $127,972,108 | 12.11% |
| Perceptive Advisors | 27,692,917 | $336,745,870 | 11.23% |
| Redmile Group, LLC | 16,944,621 | $206,046,591 | 9.80% |
| Finepoint Capital LP | 1,489,025 | $18,106,544 | 9.02% |
| CM Management, LLC | 450,000 | $5,472,000 | 5.81% |
| Avoro Capital Advisors LLC | 27,400,000 | $333,184,000 | 5.20% |
| MPM BioImpact LLC | 716,139 | $8,708,250 | 2.32% |
| Artal Group S.A. | 4,062,567 | $49,401 | 2.12% |
| SECTORAL ASSET MANAGEMENT INC | 803,464 | $9,770,122 | 1.90% |
| GREAT POINT PARTNERS LLC | 857,000 | $10,421,120 | 1.90% |